
Sign up to save your podcasts
Or


Gilead Sciences buys Kite Pharma for $12 billion in cash. Kristine Harjes and Jason Moser analyze the deal and what it means for Gilead’s future. Plus, Uber gets a new CEO (courtesy of Expedia), Fitbit rolls out a new smartwatch, and Whole Foods is now selling....Amazon Echo speakers.
By The Motley Fool4.7
16041,604 ratings
Gilead Sciences buys Kite Pharma for $12 billion in cash. Kristine Harjes and Jason Moser analyze the deal and what it means for Gilead’s future. Plus, Uber gets a new CEO (courtesy of Expedia), Fitbit rolls out a new smartwatch, and Whole Foods is now selling....Amazon Echo speakers.

3,217 Listeners

1,482 Listeners

808 Listeners

944 Listeners

521 Listeners

1,170 Listeners

2,201 Listeners

825 Listeners

1,422 Listeners

1,038 Listeners

9,715 Listeners

195 Listeners

833 Listeners

84 Listeners

584 Listeners

1,049 Listeners

56 Listeners